Publications by authors named "Michael Stepanavage"

Claim this Profile
M
Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib.
Michael Davidson, Sherry Xueyu Liu, Philip Barter, Eliot A Brinton, Christopher P Cannon, Michael Stepanavage

J Lipid Res· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of anacetrapib in patients with or at high risk for coronary heart disease.
Christopher P Cannon, Sukrut Shah, Hayes M Dansky, Michael Davidson, Eliot A Brinton, Michael Stepanavage

N Engl J Med· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design.
Robert M Califf, Yuliya Lokhnygina, Christopher P Cannon, Michael E Stepanavage, Carolyn H McCabe

Am Heart J· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin.
Susan G Lakoski, Fang Xu, Gloria L Vega, Scott M Grundy, Manisha Chandalia, Michael E Stepanavage

J Clin Endocrinol Metab· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib.
Christopher P Cannon, Hayes M Dansky, Michael Davidson, Antonio M Gotto, Eliot A Brinton, Michael Stepanavage

Am Heart J· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Striated muscle safety of ezetimibe/simvastatin (Vytorin).
Michael H Davidson, Darbie Maccubbin, Michael Stepanavage, John Strony, Thomas Musliner

Am J Cardiol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy outcomes after maternal exposure to simvastatin and lovastatin.
Pia S Pollack, Kristine E Shields, Diane M Burnett, Mary Jean Osborne, Michael L Cunningham, Michael E Stepanavage

Birth Defects Res A Clin Mol Teratol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin.
Saskia de Jongh, Leiv Ose, Tamás Szamosi, Claude Gagné, M Lambert, Michael Stepanavage

Circulation· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjects.
Peer Tfelt-Hansen, Kaj Seidelin, Michael Stepanavage, Christopher Lines

Br J Clin Pharmacol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis